Related Experiment Video
Updated: Mar 2, 2026

Minimum Volume Vitrification of Immature Feline Oocytes
Published on: June 24, 2020
Bio-inspired solute enables preservation of human oocytes using minimum volume vitrification
Jung Kyu Choi1, Rami El Assal1, Nicholas Ng2
1Bio-Acoustic-MEMS in Medicine (BAMM) Laboratories, Canary Center at Stanford for Early Cancer Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, California, USA.
Abstract:
The ability to cryopreserve human oocytes has significant potential for fertility preservation. Current cryopreservation methods still suffer from the use of conventional cryoprotectants, such as dimethyl sulphoxide (DMSO), causing loss of viability and function. Such injuries result from the toxicity and high concentration of cryoprotectants, as well as mechanical damage of cells due to ice crystal formation during the cooling and rewarming processes. Here we report the preservation of human oocytes following vitrification using an innovative bio-inspired cryoprotectant integrated with a minimum volume vitrification approach. The results demonstrate that the recovered human oocytes maintained viability following vitrification and rewarming. Moreover, when this approach was used to vitrify mouse oocytes, the recovered oocytes preserved their viability and function following vitrification and rewarming. This bio-inspired approach substitutes DMSO, a well-known toxic cryoprotectant, with ectoine, a non-toxic naturally occurring solute. The bio-inspired vitrification approach has the potential to improve fertility preservation for women undergoing cancer treatment and endangered mammal species.

